Indian Immunologicals Limited Vaccine Export Data — India (DGFT 2022–2026)

Name: Indian Immunologicals Limited Vaccine Export Records India — #6 Exporter, 403 Shipments, $20.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vaccine

India Pharmaceutical Trade Intelligence

$1.0B325 Suppliers192 CountriesHS 30024200

ExportsIndia → PAKISTAN8.5%India → NIGERIA8.1%

ImportsFRANCE → India$176.5B GERMANY → India$138.0B

#1 Supplier: SERUM INSTITUTE

Indian Immunologicals Limited — Vaccine Exporter #6 | $20.1M Trade Value | TransData Nexus | TransData Nexus

Indian Immunologicals Limited — Vaccine Exporter Profile

Indian Pharmaceutical Exporter · #6 for Vaccine · $20.1M export value · DGFT Verified

Indian Immunologicals Limited is the #6 Indian exporter of Vaccine with $20.1M in export value and 403 verified shipments. Indian Immunologicals Limited holds a 1.9% market share in Vaccine exports across 34 countries. The company exports 3 pharmaceutical products worth $29.1M across 3 therapeutic categories.

Indian Immunologicals Limited — Vaccine Export Profile: Buyers & Destinations

Indian Immunologicals Limited Vaccine export treemap — buyers and destination countries | TransData Nexus

Where Does Indian Immunologicals Limited Export Vaccine?

Country	Value	Shipments	Share
TURKEY	$2.7M	60	17.5%
PHILIPPINES	$2.6M	55	16.7%
NEPAL	$2.3M	58	14.7%
VIETNAM, DEMOCRATIC REP. OF	$1.6M	33	10.7%
VIETNAM

Who Are the Top Buyers of Vaccine from Indian Immunologicals Limited?

Buyer	Country	Value	Orders
CENTURION ILAC SANAYI VE TICARET AN	TURKEY	$2.1M	42
2 WORLD TRADERS INC	PHILIPPINES	$1.6M	33
DUC MINH MEDICAL JOINT STOCK COMPAN	VIETNAM, DEMOCRATIC REP. OF	$1.3M	26
EXCEL PHARMA	NEPAL	$767.9K	23
HYGIEIA BIOGENICS MYANMAR COMPANY L	MYANMAR	$406.0K	12
CENTURION ILAC SANAYI VE TICARET	TURKEY	$400.1K	14
I AND M BANK LTD	KENYA	$400.0K	8
NEW AVAKASH INTERNATIONAL	ZIMBABWE	$377.6K	13
DUC MINH MEDICAL JOINTS STOCK COMPA	VIETNAM, DEMOCRATIC REP. OF	$350.0K	7
DUC MINH MEDIACL JOINT STOCK COMPAN	VIETNAM, DEMOCRATIC REP. OF	$350.0K	7

Indian Immunologicals Limited supplies Vaccine to 107 buyers globally. The largest buyer is CENTURION ILAC SANAYI VE TICARET AN (TURKEY), followed by 2 WORLD TRADERS INC (PHILIPPINES) and DUC MINH MEDICAL JOINT STOCK COMPAN (VIETNAM, DEMOCRATIC REP. OF). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vaccine Formulations Does Indian Immunologicals Limited Export?

Product Description / Formulation	Value	Shipments
ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRINGE AND DILUENT)	$1.5M	30
ABHAYRAB 0.5ML B.P (HUMAN RABIES VACCINE	$903.7K	20
ABHAYRAB 0.5ML(HUMAN RABIES VACCINE WITH	$635.7K	13
ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINE	$537.7K	12
ABHAYRAB 0.5ML(HUMAN RABIES VACCINE WITHDILUENT AND SYRINGE)	$450.0K	9
ABHAYRAB 0.5ML BP(HUMAN RABIES VACCINE WITH DISPOSABLE SYRINGE AND DILUENT)	$449.7K	9
ABHAYTOX BP 0.5ML (TETANUS TOXOID VACCINE)	$385.3K	9
ABHAYRAB 0.5MLHUMAN RABIES VACCINE WITH	$300.0K	6
ABHAYRAB 0.5ML B.P HUMAN RABIES VACCINE	$251.6K	6
ABHAYRAB VACCINE(RABIES VACCINE HUMAN I.	$185.1K	4

Indian Immunologicals Limited exports 224 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ABHAYRAB 0.5ML B.P(HUMAN RABIES VACCINEWITH DISPOSABLE SYRIN with 30 shipments worth $1.5M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Indian Immunologicals Limited Compare to Nearest Vaccine Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	BIOLOGICAL E. LIMITED	$43.0M	859	104	$50.0K
3	BHARAT BIOTECH INTERNATIONAL LIMITED	$30.4M	609	77	$50.0K
6	INDIAN IMMUNOLOGICALS LIMITED ★	$20.1M	403	34	$50.0K
4	BIOLOGICAL E LIMITED	$15.7M	313	79	$50.0K
5	PANACEA BIOTEC LIMITED	$11.7M	234	58	$50.0K

Indian Immunologicals Limited ranks #6 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are BIOLOGICAL E. LIMITED and BHARAT BIOTECH INTERNATIONAL LIMITED.

Which Indian Ports Ship Vaccine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	3,489	24.3%
SAHAR AIR	2,995	20.9%
Bombay Air	855	6.0%
HYDERABAD ACC (INHYD4)	839	5.8%
HYDERABAD AIR	805	5.6%
DELHI AIR CARGO ACC (INDEL4)	752	5.2%
DELHI AIR	581	4.0%
AHEMDABAD AIR ACC (INAMD4)	373	2.6%

Geopolitical & Trade Policy Impact on Indian Immunologicals Limited's Vaccine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like IIL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels via the Cape of Good Hope. This has resulted in elongated lead times and increased shipping costs, disproportionately affecting time-sensitive pharmaceutical shipments. (pharmaceuticalcommerce.com) Additionally, the Middle East crisis has led to potential losses ranging between ₹2,500 crore and ₹5,000 crore for the Indian pharmaceutical industry due to supply chain disruptions. (outlookbusiness.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of new tariffs by the US administration, with rates reaching as high as 39% on imports from countries including India, poses a significant challenge. (apnews.com) These tariffs could impact nearly 55% of India's exports to the US, affecting long-standing client relationships and profit margins.

In the European Union, compliance with the Falsified Medicines Directive (FMD) has become imperative. Indian exporters must invest in serialization and traceability systems to meet these stringent requirements, ensuring continued access to the lucrative EU market.

Indian Immunologicals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA and WHO intensifying inspections to ensure compliance with Good Manufacturing Practices (GMP). In 2023, the US FDA conducted over 200 inspections in India, with plans to increase this number in 2024, reflecting a growing emphasis on quality assurance. (fact.net.in) For IIL, maintaining rigorous quality standards is paramount, especially in light of incidents like the circulation of counterfeit batches of its rabies vaccine, Abhayrab®, in India since 2023. (health.gov.au) Such events underscore the necessity for robust quality control measures to safeguard product integrity and public trust.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Indian Immunologicals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 419 individual customs records matching Indian Immunologicals Limited exporting Vaccine, covering 224 formulations to 40 countries via 107 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 192+ countries, 2,202+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vaccine

Vaccine

Indian Immunologicals Limited — Vaccine Exporter Profile

Indian Immunologicals Limited — Vaccine Export Profile: Buyers & Destinations

Where Does Indian Immunologicals Limited Export Vaccine?

Who Are the Top Buyers of Vaccine from Indian Immunologicals Limited?

What Is India's Total Vaccine Export Value and How Much Does Indian Immunologicals Limited Contribute?

What Is the Average Shipment Value for Indian Immunologicals Limited's Vaccine Exports?

How Does Indian Immunologicals Limited Compare to Other Indian Vaccine Exporters?

What Vaccine Formulations Does Indian Immunologicals Limited Export?

How Does Indian Immunologicals Limited Compare to Nearest Vaccine Exporters?

Which Indian Ports Ship Vaccine Exports?

Geopolitical & Trade Policy Impact on Indian Immunologicals Limited's Vaccine Exports

Indian Immunologicals Limited — Regulatory Compliance & Quality Standards

About Indian Immunologicals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vaccine Export Data from Indian Immunologicals Limited

Vaccine Stats

Company Overview

Top Products by Indian Immunologicals Limited

Related Analysis

Need Detailed Export Data?

Data Source